ICD-10 Code Category E21-: Hyperparathyroidism and Other Disorders of the Parathyroid Gland — Complete Coding & Billing Guide

What Is ICD-10 Category E21- and Why Does It Matter for Coders?

ICD-10-CM category E21- covers Hyperparathyroidism and Other Disorders of the Parathyroid Gland — a group of endocrine conditions in which the parathyroid glands produce abnormal levels of parathyroid hormone (PTH), disrupting the body’s calcium-phosphorus balance. The category spans six distinct subcodes (E21.0–E21.5) that differentiate the type, cause, and specificity of the parathyroid disorder being reported. E21- codes are part of Chapter 4 (Endocrine, Nutritional and Metabolic Diseases, E00–E89) and fall within the Disorders of Other Endocrine Glands block (E20–E35).

Key category-level facts every coder must know:

• E21 itself (without a 4th character) is NOT billable — it is a non-specific header code and cannot be submitted on a claim
• All billable codes require a 4th character: E21.0 through E21.5
• This category is effective for FY2026 (October 1, 2025 – September 30, 2026) with no structural changes from the prior year
• The ICD-10-CM Official Coding Guidelines Section I.C. do not include a dedicated chapter-specific guideline for E21-; general etiology/manifestation and specificity rules apply
• This category is frequently encountered in endocrinology, nephrology, general surgery, and internal medicine billing

What Are All the Codes in the E21- Category?

The table below maps every code in the E21- category, its billable status, and its plain-language descriptor.

ICD-10 Code	Description	Billable?
E21	Hyperparathyroidism and other disorders of parathyroid gland	❌ No — header only
E21.0	Primary hyperparathyroidism	✅ Yes
E21.1	Secondary hyperparathyroidism, not elsewhere classified	✅ Yes
E21.2	Other hyperparathyroidism	✅ Yes
E21.3	Hyperparathyroidism, unspecified	✅ Yes
E21.4	Other specified disorders of parathyroid gland	✅ Yes
E21.5	Disorder of parathyroid gland, unspecified	✅ Yes

Why Can’t E21 (Without a Digit) Be Used for Billing?

E21 without a 4th character is a non-specific parent code that functions only as a navigational header in the ICD-10-CM tabular list. Submitting it on a claim will trigger an edit rejection because the code does not meet the specificity requirements established by CMS for valid HIPAA transactions. Coders must always select the most specific available subcode — and in this category, specificity is always one of E21.0 through E21.5.

What Conditions and Diagnoses Does Each E21- Code Cover?

E21.0 — Primary Hyperparathyroidism applies when one or more parathyroid glands are intrinsically overactive due to an autonomous process originating within the gland itself. Clinical causes captured by this code include:

• Solitary parathyroid adenoma (accounts for roughly 85% of primary cases)
• Parathyroid hyperplasia (multiglandular disease)
• Parathyroid carcinoma (rare, approximately 1% of cases)
• Primary hyperparathyroidism in the setting of Multiple Endocrine Neoplasia (MEN) type 1 or 2A

The hallmark biochemical profile is simultaneous hypercalcemia and elevated intact PTH — an autonomous gland does not suppress in response to rising serum calcium.

E21.1 — Secondary Hyperparathyroidism, Not Elsewhere Classified captures cases where the parathyroid glands are responding appropriately — but excessively — to a chronic low-calcium stimulus arising from a non-renal source. Causes include:

• Vitamin D deficiency or malabsorption (celiac disease, bariatric surgery, inflammatory bowel disease)
• Nutritional calcium deficiency
• Malabsorption syndromes causing chronic hypocalcemia
• Osteomalacia of non-renal origin

Critical note: Secondary hyperparathyroidism caused by chronic kidney disease (CKD) or renal failure is NOT coded E21.1. It maps to N25.81 (Secondary hyperparathyroidism of renal origin) — a separate code outside the E21- block entirely.

E21.2 — Other Hyperparathyroidism is used for tertiary hyperparathyroidism, a condition that develops when a previously secondary (usually renal) hyperparathyroid state becomes autonomous after prolonged stimulation — most commonly seen after renal transplantation when the glands have become self-driving despite restored renal function.

E21.3 — Hyperparathyroidism, Unspecified applies only when the provider confirms hyperparathyroidism but cannot or does not specify whether it is primary, secondary, or tertiary in origin. This should be a last resort after a provider query.

E21.4 — Other Specified Disorders of Parathyroid Gland captures documented parathyroid disorders that do not fit neatly into any above subcategory — for example, hypoparathyroidism-related hypercalcemic rebound or unusual parathyroid cysts when separately documented as a disorder.

E21.5 — Disorder of Parathyroid Gland, Unspecified is the least specific code in the category, appropriate only when documentation references parathyroid disease with no further clinical characterization available.

What Does the E21- Category Specifically Exclude?

The following conditions are explicitly excluded from E21- and must be coded elsewhere:

• Adult osteomalacia → M83.- (Excludes1 — never code with E21-)
• Ectopic hyperparathyroidism (PTH secreted by non-parathyroid tumor) → E34.2
• Hungry bone syndrome (post-parathyroidectomy hypocalcemia) → E83.81
• Infantile and juvenile osteomalacia → E55.0 (Excludes1)
• Familial hypocalciuric hypercalcemia → E83.52 (Excludes2 — may coexist but requires separate code)
• Secondary hyperparathyroidism of renal origin → N25.81 (outside the E21- block)

When Is Each E21- Code the Right Code to Use?

Choosing the correct E21- subcode hinges on two questions: (1) Is the parathyroid overactivity primary or secondary? and (2) If secondary, is the cause renal or non-renal? Follow this decision path:

1. Is PTH elevated due to an intrinsic parathyroid problem (adenoma, hyperplasia, carcinoma)? → E21.0 (primary hyperparathyroidism)
2. Is PTH elevated in response to CKD or end-stage renal disease? → N25.81 (secondary hyperparathyroidism of renal origin) — do NOT use any E21- code here
3. Is PTH elevated in response to a non-renal cause (vitamin D deficiency, malabsorption)? → E21.1 (secondary hyperparathyroidism, not elsewhere classified)
4. Has the patient had longstanding secondary HPT — especially post-renal transplant — and the glands are now autonomous despite resolution of the original stimulus? → E21.2 (other hyperparathyroidism = tertiary HPT)
5. Is hyperparathyroidism confirmed but the type cannot be determined from available documentation? → Query the provider; if still unresolvable → E21.3
6. Is a parathyroid disorder confirmed but not further described? → E21.5

How Do the E21- Codes Compare to Each Other and to N25.81?

Code	Type	Cause	Calcium Level	Key Distinguishing Feature
E21.0	Primary HPT	Intrinsic (adenoma, hyperplasia, carcinoma)	High	Autonomous — gland does not suppress with high Ca²⁺
E21.1	Secondary HPT	Non-renal (vit D deficiency, malabsorption)	Low-normal	Reactive — gland responds to low calcium signal
E21.2	Tertiary HPT	Post-secondary autonomy (often post-transplant)	High	Evolved from secondary → became autonomous
E21.3	Unspecified HPT	Unknown	Variable	Use only when type is undocumented after query
E21.4	Other specified	Specified but atypical	Variable	Document must name the specific disorder
E21.5	Unspecified disorder	Unknown	Variable	Broadest, least specific — avoid if possible
N25.81	Secondary HPT	Renal (CKD, ESRD)	Low-normal	NOT an E21- code — lives in genitourinary chapter

In practice, the most frequent selection error is assigning E21.1 to a patient with CKD-driven secondary hyperparathyroidism. The alphabetic index directs coders to N25.81 for secondary hyperparathyroidism as the default — coders should use E21.1 only when documentation explicitly states a non-renal cause.

What Documentation Is Required to Support E21- Codes?

What Must the Provider Document in the Clinical Notes?

Documentation requirements vary slightly by subcode, but the following elements are needed across the board:

1. Explicit diagnosis terminology — the provider must use terminology like “primary hyperparathyroidism,” “secondary hyperparathyroidism due to vitamin D deficiency,” or “tertiary hyperparathyroidism” — generic terms like “elevated PTH” or “parathyroid issue” do not support code assignment without further specificity
2. Cause or etiology — for E21.1, the non-renal cause must be named; for E21.2, documentation of the prior chronic stimulus (e.g., long-standing CKD followed by transplant) should appear in the record
3. Lab values supporting the diagnosis — serum calcium, intact PTH, phosphorus, and 25-OH vitamin D levels as appropriate
4. Imaging results — for E21.0, sestamibi scan, neck ultrasound, or four-dimensional CT findings confirming adenoma or hyperplasia when available
5. Surgical pathology — when a parathyroidectomy has been performed, pathology must support the operative diagnosis

Which Diagnostic or Lab Results Support Each E21- Code?

• E21.0 (Primary HPT): Serum calcium >10.5 mg/dL on two occasions; intact PTH >65 pg/mL; 24-hour urinary calcium >200 mg/day; sestamibi scintigraphy or neck ultrasound confirming adenoma or hyperplasia; DEXA scan showing reduced bone mineral density
• E21.1 (Secondary HPT, non-renal): Serum 25-OH vitamin D <20 ng/mL; serum calcium low-normal; elevated PTH; malabsorption documented on endoscopy or serologic testing; eGFR within normal limits (ruling out renal cause)
• E21.2 (Tertiary HPT): History of prior secondary HPT (typically renal); post-transplant records; persistent hypercalcemia and autonomous PTH elevation after transplant or correction of original stimulus
• E21.3 (Unspecified HPT): Confirmed PTH elevation with hypercalcemia, but no etiology documented — provider has been queried and cannot further specify

What Is the Documentation Standard for Inpatient vs. Outpatient Settings?

Setting	Documentation Standard
Outpatient	Code only confirmed diagnoses; do not code “rule-out” or “suspected” hyperparathyroidism; code lab abnormalities (e.g., hypercalcemia R83.8x) separately if the diagnosis is not yet confirmed
Inpatient	”Probable,” “likely,” or “suspected” hyperparathyroidism may be coded at discharge per ICD-10-CM Official Coding Guidelines Section II
Post-surgical	Code the condition that led to surgery; if a parathyroidectomy was performed, add the appropriate surgical complication code if applicable (e.g., E89.2 for post-procedural hypoparathyroidism)

How Do E21- Codes Affect Medical Billing and Claims?

E21- codes are the primary diagnosis drivers for a distinct set of endocrine and surgical services. Key billing considerations include:

• MS-DRG grouping: E21.0, E21.1, and E21.2 fall within MS-DRG V43.0 groupings for endocrine disorders with and without complications/comorbidities — accurate code selection directly affects DRG weight and inpatient reimbursement
• Medical necessity for imaging: Payers require E21.0 or a confirmed hyperparathyroidism code to approve sestamibi nuclear medicine scans; “elevated PTH” alone (coded as a lab finding) may not meet medical necessity thresholds
• Surgical justification: CPT 60500 (parathyroidectomy) requires a confirmed E21.0, E21.2, or E21.3 diagnosis with supporting lab and imaging documentation — secondary hyperparathyroidism (E21.1 or N25.81) may also support surgery if severe and medically documented
• Outpatient vs. physician claim alignment: Ensure the ICD-10 code on the facility claim matches the treating provider’s professional claim — mismatches on E21.0 vs. E21.3 are an audit trigger

What CPT or Procedure Codes Are Commonly Billed With E21- Codes?

CPT Code	Description	Typical E21- Pairing
60500	Parathyroidectomy or exploration of parathyroid(s)	E21.0 (primary HPT with adenoma or hyperplasia)
60502	Re-exploration of parathyroid(s)	E21.0 or E21.2 (persistent/recurrent disease)
78071	Parathyroid imaging (sestamibi scan); planar	E21.0 (pre-operative adenoma localization)
78072	Parathyroid imaging with SPECT or SPECT/CT	E21.0 (enhanced localization for minimally invasive surgery)
82310	Calcium, total, serum	E21.0, E21.1, E21.2, E21.3 (monitoring)
83519	Immunoassay for analyte (intact PTH)	All E21- codes (diagnosis and monitoring)
77080	DEXA bone density study	E21.0 (bone disease assessment)
99213–99215	Office/outpatient E&M	All E21- codes (endocrine/nephrology follow-up)

Are There Any Prior Authorization or Coverage Restrictions?

• Sestamibi nuclear imaging (78071/78072) typically requires prior authorization under commercial plans; E21.0 must be confirmed — suspected or rule-out diagnoses may not qualify
• Parathyroidectomy (60500) is generally covered under Medicare when E21.0 is documented with supporting biochemical and imaging evidence; some MACs require review of DEXA and calcium trends
• Cinacalcet (Sensipar) or etelcalcetide for secondary HPT requires E21.1 or N25.81 and often CKD staging codes (N18.x) and dialysis status (Z99.2) for prior authorization under Medicare Part D or commercial pharmacy benefits

What Coding Errors Should You Avoid With E21- Codes?

Auditors and payer reviewers consistently flag these errors in E21- claims:

1. Using E21.1 when the cause is renal. Secondary hyperparathyroidism caused by CKD must be coded N25.81 — not E21.1. The alphabetic index leads to N25.81 as the default for secondary HPT; E21.1 is reserved for documented non-renal etiology.
2. Submitting E21 (no digit) as a billable code. The header code is never payable and will be rejected. Always append the 4th character.
3. Using E21.3 (unspecified) without querying the provider. Defaulting to unspecified when more specific information is likely available is a specificity failure under coding compliance standards.
4. Coding E21.0 based on lab abnormalities alone. Elevated PTH and calcium are signs — they support a diagnosis but do not replace it. The provider must state the diagnosis in the clinical note.
5. Assigning E21.2 (tertiary HPT) without clinical context. Tertiary hyperparathyroidism has a specific clinical backstory. Coding it without documentation of prior chronic secondary stimulation — particularly the post-transplant scenario — is unsupported.
6. Failing to code the underlying cause alongside E21.1. If secondary HPT is due to documented vitamin D deficiency, code E55.9 (or the specific vitamin D deficiency code) alongside E21.1 to complete the clinical picture.
7. Missing the hungry bone syndrome exclusion. Post-parathyroidectomy hypocalcemia maps to E83.81 — do not attempt to capture this under E21-.

What Do Auditors Look for When Reviewing E21- Claims?

• Lab reports (serum calcium, intact PTH, phosphorus, vitamin D) present in the medical record and consistent with the coded diagnosis type
• Imaging reports in the file when E21.0 is coded with CPT 60500 (parathyroidectomy)
• Provider specialty consistency — endocrinology, nephrology, or general surgery notes expected; E21.0 coded on a primary care claim without specialist documentation triggers scrutiny
• Alignment between surgical operative report diagnosis and the ICD-10 code submitted
• Evidence that N25.81 was considered and appropriately differentiated when E21.1 is coded in a patient with concurrent renal disease

How Does E21- Relate to Other ICD-10 Codes?

Related Code	Chapter	Relationship to E21-	Key Distinction
N25.81	Genitourinary	Sibling concept — secondary HPT of renal origin	Used INSTEAD of E21.1 when CKD is the cause
E34.2	Endocrine	Excludes1 from E21-	Ectopic PTH secretion by non-parathyroid tumor
E83.52	Metabolic	Excludes2 from E21-	Familial hypocalciuric hypercalcemia — can coexist
E83.81	Metabolic	Excludes1 from E21-	Hungry bone syndrome (post-parathyroidectomy)
D35.1	Neoplasms	Common companion to E21.0	Benign neoplasm of parathyroid gland (adenoma)
E89.2	Post-procedural	Post-surgical sequela	Post-procedural hypoparathyroidism after parathyroidectomy
E55.9	Nutritional	Cause code for E21.1	Vitamin D deficiency driving secondary HPT
N18.x	Genitourinary	Cause code used with N25.81	CKD stage — code alongside N25.81 (not E21.1)
M83.-	Musculoskeletal	Excludes1 from E21-	Adult osteomalacia — never coded simultaneously

What Is the Correct Code Sequencing When E21- Codes Appear With Other Diagnoses?

Per the ICD-10-CM Official Coding Guidelines general sequencing rules:

1. Sequence E21.0 as principal diagnosis when the encounter is for evaluation, management, or surgical treatment of primary hyperparathyroidism.
2. For E21.1: Sequence E21.1 first, then add the underlying non-renal cause code (e.g., E55.9 for vitamin D deficiency) as a secondary code — this completes the clinical narrative.
3. For N25.81 (renal secondary HPT): Sequence N25.81 after the CKD code (N18.x) in most outpatient encounters, or per DRG principal diagnosis logic for inpatient; do not replace with E21.1.
4. For E21.2 (tertiary HPT): Sequence E21.2 as the primary diagnosis; may appear alongside transplant status codes (Z94.0 for kidney transplant status) when the post-transplant context is relevant.
5. Never code E21 (header) and a specific subcode simultaneously — the specificity of the subcode supersedes the category header.

Real-World Coding Scenario — How E21- Codes Are Applied in Practice

A 58-year-old male with a 12-year history of CKD Stage 4 receives a living-donor kidney transplant. Six months post-transplant, his renal function is stable (eGFR 55), but labs show persistent serum calcium of 11.3 mg/dL and intact PTH of 310 pg/mL. His nephrologist documents: “Patient has tertiary hyperparathyroidism, autonomous PTH secretion post-renal transplant. Calcium persistently elevated despite normalized renal function. Considering cinacalcet vs. parathyroidectomy.”

Correct Code Application

• E21.2 — Other hyperparathyroidism (= tertiary HPT; autonomous gland post-transplant, correctly captured here)
• Z94.0 — Kidney transplant status (relevant clinical context)
• N18.2 — CKD Stage 2 (current functional status post-transplant if documented)
• CPT 83519 — Intact PTH measurement
• CPT 82310 — Total serum calcium
• CPT 99214 — Established patient E&M visit

Common Mistake in This Scenario

• Assigning N25.81 (secondary HPT of renal origin) — this was the correct code pre-transplant when CKD was active, but now the gland is autonomous; N25.81 describes reactive HPT, not autonomous post-secondary disease
• Alternatively, assigning E21.1 — also incorrect, as E21.1 captures non-renal secondary HPT, not the autonomous tertiary state
• Omitting Z94.0 — the transplant status is clinically significant and should be reported to capture the full clinical picture

Frequently Asked Questions About ICD-10 Category E21-

Is ICD-10 Category E21- Valid for Use in 2026?

The E21- code category and all its subcodes (E21.0 through E21.5) are valid and billable for ICD-10-CM FY2026, effective October 1, 2025 through September 30, 2026, with no changes to code descriptions or validity status. Coders should verify annually against the official ICD-10-CM release posted on CMS.gov since endocrine coding has seen periodic expansion in adjacent code sets.

What Is the Difference Between E21.1 and N25.81 for Secondary Hyperparathyroidism?

E21.1 is used for secondary hyperparathyroidism caused by a non-renal source such as vitamin D deficiency or malabsorption, while N25.81 is used specifically when chronic kidney disease or renal failure is the driving cause. The ICD-10-CM alphabetic index defaults to N25.81 for secondary hyperparathyroidism — coders should route to E21.1 only when the provider explicitly documents a non-renal etiology. Using E21.1 for a CKD patient is a common and audit-flagged error.

When Should a Coder Use E21.3 (Unspecified) Instead of E21.0 or E21.1?

E21.3 should be assigned only after a provider query has been attempted and the provider still cannot or will not further specify whether the hyperparathyroidism is primary or secondary. In practice, a provider note that simply states “hyperparathyroidism” without further qualification warrants a query before defaulting to E21.3, since most active clinical workups will support a more specific subcode selection.

What Is Tertiary Hyperparathyroidism and Why Does It Use E21.2?

Tertiary hyperparathyroidism occurs when the parathyroid glands have been chronically stimulated by secondary HPT (most commonly renal) for so long that they develop autonomous function — meaning they continue to secrete excess PTH even after the original stimulus is corrected, such as after a successful kidney transplant. Because this is no longer a reactive secondary state nor a primary intrinsic gland problem, it does not fit E21.0 or E21.1; ICD-10-CM E21.2 (Other hyperparathyroidism) is the designated code for this clinical scenario.

What CPT Codes Are Most Commonly Billed With E21.0 for Primary Hyperparathyroidism?

The most frequent CPT pairings with E21.0 are 60500 (parathyroidectomy, the definitive surgical treatment), 78071–78072 (parathyroid sestamibi scintigraphy for adenoma localization), and 82310/83519 (serum calcium and intact PTH lab monitoring). DEXA bone density scanning (CPT 77080) is also commonly paired when bone disease complications are evaluated. Each of these services requires E21.0 to establish medical necessity per most payer policies and applicable Local Coverage Determinations.

Can E21.0 and D35.1 Be Coded Together?

Yes. E21.0 (primary hyperparathyroidism) and D35.1 (benign neoplasm of parathyroid gland) may be assigned together when a parathyroid adenoma is confirmed — E21.0 captures the functional disorder while D35.1 identifies the underlying neoplasm. This dual-coding approach is appropriate and common in surgical encounters where the adenoma is the confirmed cause of primary HPT. Pathology confirmation of benign status is required to support D35.1.

Is E21.5 Appropriate to Use When a Patient Has an Abnormal Parathyroid Finding on Imaging But No Confirmed Diagnosis?

No. Imaging findings alone do not support the assignment of E21.5 or any other E21- code in an outpatient setting. Under outpatient coding guidelines, coders report only confirmed diagnoses. If the provider documents an abnormal parathyroid finding without a confirmed diagnosis, report the imaging abnormality or the sign/symptom (e.g., hypercalcemia R83.8x or elevated PTH R79.89) until a definitive diagnosis is established.

Key Takeaways

Every coder and biller working with E21- should internalize these core points:

• E21 (no digit) is never billable — always select E21.0 through E21.5 based on clinical documentation
• E21.1 is NOT for CKD-driven secondary HPT — that routes to N25.81 in the genitourinary chapter; this is the single most common E21- coding error in nephrology and endocrine billing
• E21.2 captures tertiary hyperparathyroidism — an autonomous post-secondary state, most commonly encountered in post-renal-transplant patients with persistent hypercalcemia
• E21.3 and E21.5 should be last resorts — always query the provider before assigning unspecified codes, as specificity directly affects DRG weight, medical necessity, and audit defensibility
• Lab and imaging documentation must align with the coded subtype — an adenoma on sestamibi supports E21.0; vitamin D deficiency labs support E21.1; CKD stage documentation supports N25.81
• Parathyroidectomy (CPT 60500) is the most common high-value procedure paired with E21.0 — ensure operative notes, pre-op labs, and imaging are all present in the record before surgical claims are submitted
• For the most current guidance, refer to the ICD-10-CM Official Coding Guidelines on CMS.gov and the AHA Coding Clinic for any coding advisories related to parathyroid disorder specificity

For additional guidance on medical billing documentation requirements, coding audit preparation, and revenue cycle compliance for endocrine disorders, reference the ICD-10-CM Official Coding Guidelines and applicable Local Coverage Determinations from your Medicare Administrative Contractor.